🔎 Trials Near Me

ホーム › 地図状萎縮 › ネバダ州

ネバダ州における地図状萎縮の臨床試験

ネバダ州内の拠点で、地図状萎縮に関する8件の研究が参加者を募集しています。

ネバダ州内の都市

公式研究テキスト（英語）

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Sierra Eye Associates, Reno
被験者募集中第2/3相
60歳以上 · 全性別 · 2026/09/30更新 · NCT06635148

A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Sierra Eye Associates, Reno
被験者募集中第1/2相
55歳以上 · 全性別 · 2026/09/23更新 · NCT07029945

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  • Sierra Eye Associates- Site Number : 8400021, Reno
被験者募集中第1/2相
60歳以上 · 全性別 · 2026/09/22更新 · NCT07215234

A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251

  • Sierra Eye Associates, Reno
被験者募集中第2相
50歳以上 · 全性別 · 2026/09/15更新 · NCT05626114

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • Sierra Eye Associates, Reno
被験者募集中第2相
55歳以上 · 全性別 · 2026/09/10更新 · NCT06659445

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

  • Sierra Eye Associates, Reno
被験者募集中観察研究
55歳以上 · 全性別 · 2026/09/03更新 · NCT07144137

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

  • Sierra Eye Associates, Reno
被験者募集中
60歳以上 · 全性別 · 2026/08/26更新 · NCT06662162

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  • Sierra Eye Associates /ID# 262142, Reno
被験者募集中第1/2相
50歳以上 · 全性別 · 2026/07/13更新 · NCT07160179

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。